WINDWARD BIO GROUP AG
WWBNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for WWB. That does not mean none is planned.
Get an email about WWB's next catalysts
Track WINDWARD BIO GROUP (WWB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 0 past
No catalysts found.
Market Overview
Stock performance and key metrics
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
WIN378 | Phase 2 | COPD (Chronic Obstructive Pulmonary Disease) | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in WINDWARD BIO GROUP AG's drug pipeline?β
CatalystAlert tracks 1 drug candidate in WINDWARD BIO GROUP AG's (WWB) pipeline across Phase 2. Its lead program is WIN378 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is WINDWARD BIO GROUP AG's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for WINDWARD BIO GROUP AG (WWB) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track WWB biotech catalysts?β
Add WWB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow WINDWARD BIO GROUP AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
